Keywords: درمان ترکیبی; PAH; Combination therapy; DDIsPAH, pulmonary arterial hypertension; DDI, drug–drug interaction; ERAs, endothelin receptor antagonists; PDE5, phosphodiesterase type 5; OATP, organic anion transporting polypeptide; MDR1, multidrug resistance protein 1; AUC,
مقالات ISI درمان ترکیبی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: درمان ترکیبی; Combination therapy; Rubinstein–Taybi syndrome; Cognitive disorders; Drug synergism; Long-term memory
Keywords: درمان ترکیبی; Adjuvant chemotherapy; Combination therapy; Elderly; Survival; Toxicity;
Keywords: درمان ترکیبی; Inflammation; Cancer; Combination therapy; Nanohydrogel; Drug solubility; Prednisolone; Paclitaxel
Keywords: درمان ترکیبی; Upconversion nanoparticles; Toxicity; Photothermal therapy; Photodynamic therapy; Combination therapy;
Keywords: درمان ترکیبی; biologics; combination therapy; comparative effectiveness; Dermatology Life Quality Index; Physician Global Assessment; psoriasis; quality of life; systemic treatments; BSA; body surface area; DLQI; Dermatology Life Quality Index; FDA; Food and Drug Admin
Keywords: درمان ترکیبی; Graft copolymer; Micelle; Combination therapy; Bio-inspired; Ring open polymerization; Nanomedicine;
Keywords: درمان ترکیبی; Pentoxifylline; Lipodox; Combination therapy; Breast cancer; Xenograft model
Keywords: درمان ترکیبی; Hypocrellin A; 7-Ethyl-10-hydroxycamptothecin; Graphene oxide; Combination therapy
Keywords: درمان ترکیبی; Immunotherapy; Hyperthermia; Chemotherapy; CpG ODNs; Combination therapy;
Keywords: درمان ترکیبی; combination therapy; myelofibrosis; ruxolitinib; panobinostat; decitabine; LDE225; PRM-151
Keywords: درمان ترکیبی; Melanoma; BRAF; Mitogen-activated extracellular kinase; Immunotherapy; Combination therapy; Targeted therapy;
Keywords: درمان ترکیبی; Colistin; Colistimethate sodium; Polymyxin; Pseudomonas aeruginosa; Multi-drug resistance; Blood-stream infections; Bacteraemia; Strategy; Dosing; Combination therapy
Keywords: درمان ترکیبی; Cancer treatment; Polymeric nanomedicines; Combination therapy; Polyglutamic acid; Chemotherapy; Drug-polymer conjugates;
Keywords: درمان ترکیبی; Antibiotics; Antimicrobial polymers; Biofilm; Quorum sensing; Combination therapy; Nanoparticle delivery
Keywords: درمان ترکیبی; BRAFV600; Melanoma; Drug resistance; MAPK; PI3K/AKT; Tumor heterogeneity; Combination therapy;
Keywords: درمان ترکیبی; Glucocorticoid; Combination therapy; Steroid resistance; Inflammation; Chronic airway diseases; Asthma;
Keywords: درمان ترکیبی; Statin; LDL-C; Ezetimibe; Niacin; Fibrate; Combination therapy; PCSK9;
Keywords: درمان ترکیبی; Combination therapy; Nanoparticles; Drug delivery; Paclitaxel; Doxorubicin;
Keywords: درمان ترکیبی; Orlistat; Serotonergic drugs; Sympathomimetic drugs; Glucagon-like peptide-1 agonists; Combination therapy
Keywords: درمان ترکیبی; Melanoma; Prognosis; Biology; Immunotherapy; Targeted therapies; Neoadjuvant; Adjuvant; Combination therapy;
Keywords: درمان ترکیبی; Pseudomonas aeruginosa; Bacteraemia; Antibiotic; Combination therapy; Monotherapy; Mortality;
Keywords: درمان ترکیبی; Erlotinib; Bevacizumab; Non-squamous; Non-small cell lung cancer; First-line; Combination therapy;
Keywords: درمان ترکیبی; Hsp70; Hsp40; Hsp27; Cancer; Combination therapy;
Keywords: درمان ترکیبی; Refractory status epilepticus; Clonazepam; Treatment delay; Outcome criteria; Combination therapy;
Keywords: درمان ترکیبی; Seesaw effect; MRSA; hVISA/VISA/VRSA; Combination therapy; Daptomycin nonsusceptible;
Keywords: درمان ترکیبی; Vascular-targeted photodynamic therapy (vPDT); Verteporfin; Reactive oxygen species (ROS); Bortezomib; Ubiquitination; Apoptosis; Combination therapy;
Keywords: درمان ترکیبی; Vemurafenib; Melanoma; Drug resistance; Toxicity; Squamous cell carcinoma; Combination therapy;
Keywords: درمان ترکیبی; Combination therapy; Ischemia/reperfusion; Apoptotic cell death; Stroke;
Keywords: درمان ترکیبی; Eldecalcitol; ELD; Alfacalcidol; Alendronate; Combination therapy; Additive effect;
Keywords: درمان ترکیبی; 5-Fluorouracil; Parthenolide; Combination therapy; Anti-cancer; Colorectal cancer;
Keywords: درمان ترکیبی; Meta-analysis; Advanced pancreatic cancer; Gemcitabine; Combination therapy;
Keywords: درمان ترکیبی; Proteasome; Tumor targeting; Combination therapy; RGD; Bacteriophage;
Keywords: درمان ترکیبی; Tumor interstitial fluid pressure; Intratumoral delivery; Combination therapy; Imatinib; Doxorubicin; Sterically stabilized liposome;
Keywords: درمان ترکیبی; angiotensin receptor blocker; calcium channel blocker; combination therapy; lipid metabolism; thiazide;
Keywords: درمان ترکیبی; asthma; combination therapy; formoterol; fluticasone; inhaled corticosteroid; long-acting β2-agonist;
Keywords: درمان ترکیبی; siRNA; small interfering RNA; AON; antisense oligonucleotides; shRNA; small hairpin RNA; pDNA; plasmid DNA; CYP3A; cytochrome P450 3A; MDR; multidrug resistance; MDR1; multidrug resistance protein 1; Pgp; P-glycoprotein; TRAIL; tumor necrosis factor-relat
Keywords: درمان ترکیبی; combination therapy; COPD; long-acting β2-agonist (LABA); long-acting muscarinic antagonist (LAMA)DPI, dry powder inhaler; FDA, US Food and Drug Administration; FDC, fixed-dose combination; LABA, long-acting β2-agonist; LAMA, long-acting muscarinic antago
Osteonecrosis of the Jaw in a Patient With Bone Metastatic Prostate Cancer After Long-term Bisphosphonate Treatment With Severe Deterioration Following Radium-223
Keywords: درمان ترکیبی; Adverse event; Bone metastases; Castrate-resistant prostate cancer; Combination therapy; Jaw necrosis;
Comparison of induction therapy in non-high risk acute promyelocytic leukemia with arsenic trioxide or in combination with ATRA
Keywords: درمان ترکیبی; Acute promyelocytic leukemia; Arsenic trioxide; ATRA; Combination therapy;
Enhanced targeted anticancer potential of AKT-1 siRNA, an inhibitor of Protein Kinase B, in combination with silver nanoparticle against non-small cell lung adenocarcinoma
Keywords: درمان ترکیبی; Silver nanoparticle; AKT1-siRNA; Lung adenocarcinoma; Combination therapy;
Multi-resistant Gram negative Enterobactericeae in paediatrics: an infection prevention and control challenge
Keywords: درمان ترکیبی; carbapenem resistance; carbapenemase; combination therapy; E. coli; Enterobacteriaceae; infection control; Klebsiella; paediatric infection;
Refactory Trigeminal Neuralgia successfully treated by combination therapy (Pregabalin plus Lamotrigine)
Keywords: درمان ترکیبی; Combination therapy; Lamotrigine; Multiple Sclerosis; Pregabalin; Trigeminal Neuralgia;
S-allylmercaptocysteine attenuates posaconazole-induced adverse effects in mice through antioxidation and anti-inflammation
Keywords: درمان ترکیبی; Posaconazole-loaded enteric microparticles (POS); SAMC; Combination therapy;
Safety and activity findings from a phase 1b escalation study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with carboplatin in patients with platinum-sensitive ovarian cancer
Keywords: درمان ترکیبی; Antibody-drug conjugate; Combination therapy; Clinical trial; Ovarian cancer;
Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals
Keywords: درمان ترکیبی; Acinetobacter baumannii; Carbapenem; Carbapenem-resistant Gram-negative bacilli; Combination therapy; Enterobacteriaceae; Polymyxin; Pseudomonas aeruginosa; Survey;
Rates of escalation to triple COPD therapy among incident users of LAMA and LAMA/LABA
Keywords: درمان ترکیبی; Combination therapy; COPD; Inhaled corticosteroids; Long-acting bronchodilators; LAMA/LABA; Fixed-dose dual bronchodilators; CDS; Chronic Disease Score; CI; confidence interval; COPD; chronic obstructive pulmonary disease; ER; emergency room; FDC; fixed-d
Growth-inhibition of S180 residual-tumor by combination of cyclophosphamide and chitosan oligosaccharides in vivo
Keywords: درمان ترکیبی; Chitosan oligosaccharides; Cyclophosphamide; Residual-tumor model; Anti-tumor effect; Combination therapy;
DANFIN functions as an inhibitor of transcription factor NF-κB and potentiates the antitumor effect of bortezomib in multiple myeloma
Keywords: درمان ترکیبی; NF-κB; DANFIN; Bortezomib; Multiple myeloma; Cell-free; Combination therapy;
Combination effects of alogliptin and pioglitazone on steatosis and hepatic fibrosis formation in a mouse model of non-alcoholic steatohepatitis
Keywords: درمان ترکیبی; Nonalcoholic steatohepatitis; Hepatic fibrosis; Alogliptin; Pioglitazone; Combination therapy;